Aperture Therapeutics is a biotechnology company developing a new class of therapeutics to treat injury- and age-induced neurodegeneration. The company's innovative platform leverages insight into disease resilience from large genomic and clinical data with streamlined drug discovery platform that generates drugs mimicking the effects of protective human gene variants.
Company Details
- Employees
- 6
- Founded
- 2022
- Address
- 733 Industrial Rd, San Carlos,california 94070,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://aperturetx.com
- HQ
- San Carlos, California
Aperture Therapeutics Questions
Aperture Therapeutics's website is http://aperturetx.com
Aperture Therapeutics's LinkedIn profile is https://www.linkedin.com/company/aperture-therapeutics
Aperture Therapeutics has
6 employees.
View email and phone details for 6
employees at Aperture Therapeutics.
Aperture Therapeutics's industry is
Biotechnology Research
Aperture Therapeutics's top competitors are
Xylo Bio,
Allogene Therapeutics,
Neucyte,
Genentech,
Bridgebio,
Serotiny,
Retro Biosciences,
Kerna Labs,
Deep Genomics,
Xeia Venture Partners.
Aperture Therapeutics's categories are Biotechnology Research
Aperture Therapeutics's founding year is 2022
